These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 25829251

  • 1. MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.
    Liu X, Lei Q, Yu Z, Xu G, Tang H, Wang W, Wang Z, Li G, Wu M.
    Oncotarget; 2015 Apr 10; 6(10):7930-43. PubMed ID: 25829251
    [Abstract] [Full Text] [Related]

  • 2. LncRNA SNHG6 promotes LMO3 expression by sponging miR-543 in glioma.
    Zhang Y, An J, Pei Y.
    Mol Cell Biochem; 2020 Sep 10; 472(1-2):9-17. PubMed ID: 32613482
    [Abstract] [Full Text] [Related]

  • 3. miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.
    Lei Q, Liu X, Fu H, Sun Y, Wang L, Xu G, Wang W, Yu Z, Liu C, Li P, Feng J, Li G, Wu M.
    Oncotarget; 2016 Jan 26; 7(4):5007-22. PubMed ID: 26701852
    [Abstract] [Full Text] [Related]

  • 4. CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma.
    Xiaoping L, Zhibin Y, Wenjuan L, Zeyou W, Gang X, Zhaohui L, Ying Z, Minghua W, Guiyuan L.
    Cell Death Dis; 2013 Jun 20; 4(6):e675. PubMed ID: 23788032
    [Abstract] [Full Text] [Related]

  • 5. LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.
    Ohara Y, Craig AJ, Liu H, Yang S, Moreno P, Dorsey TH, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP.
    Carcinogenesis; 2024 Jul 08; 45(7):475-486. PubMed ID: 38366633
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma.
    Jin C, Zhao J, Zhang ZP, Wu M, Li J, Xiao GL, Liu B, Liao YX, Liu JP.
    J Neurooncol; 2020 Jul 08; 148(3):529-543. PubMed ID: 32472311
    [Abstract] [Full Text] [Related]

  • 7. LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3β signaling.
    Qiu YS, Jiang NN, Zhou Y, Yu KY, Gong HY, Liao GJ.
    Int J Mol Med; 2018 May 08; 41(5):2755-2763. PubMed ID: 29436606
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Xuan YW, Liao M, Zhai WL, Peng LJ, Tang Y.
    Eur Rev Med Pharmacol Sci; 2019 Oct 08; 23(19):8411-8421. PubMed ID: 31646571
    [Abstract] [Full Text] [Related]

  • 9. Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.
    Wang W, Ji G, Xiao X, Chen X, Qin WW, Yang F, Li YF, Fan LN, Xi WJ, Huo Y, Wen WH, Yang AG, Wang T.
    Oncotarget; 2016 Oct 18; 7(42):68674-68687. PubMed ID: 27626692
    [Abstract] [Full Text] [Related]

  • 10. Lmo3 deficiency in the mouse is associated with alterations in mood-related behaviors and a depression-biased amygdala transcriptome.
    Reisinger SN, Bilban M, Stojanovic T, Derdak S, Yang J, Cicvaric A, Horvath O, Sideromenos S, Zambon A, Monje FJ, Boehm S, Pollak DD.
    Psychoneuroendocrinology; 2020 Jan 18; 111():104480. PubMed ID: 31707294
    [Abstract] [Full Text] [Related]

  • 11. CircRNA SEPT9 contributes to malignant behaviors of glioma cells via miR-432-5p-mediated regulation of LASP1.
    Yue L, Wang G, Zhu M.
    Brain Res; 2021 Sep 01; 1766():147501. PubMed ID: 33915163
    [Abstract] [Full Text] [Related]

  • 12. LMO3 reprograms visceral adipocyte metabolism during obesity.
    Wagner G, Fenzl A, Lindroos-Christensen J, Einwallner E, Husa J, Witzeneder N, Rauscher S, Gröger M, Derdak S, Mohr T, Sutterlüty H, Klinglmüller F, Wolkerstorfer S, Fondi M, Hoermann G, Cao L, Wagner O, Kiefer FW, Esterbauer H, Bilban M.
    J Mol Med (Berl); 2021 Aug 01; 99(8):1151-1171. PubMed ID: 34018016
    [Abstract] [Full Text] [Related]

  • 13. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
    Qin WX, Shi Y, Zhu D, Li YP, Chen YH, Cui J, Cui GY, Pan JX, Ren ZY.
    Eur Rev Med Pharmacol Sci; 2020 Mar 01; 24(6):3204-3214. PubMed ID: 32271438
    [Abstract] [Full Text] [Related]

  • 14. Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression.
    Dupain C, Gracia C, Harttrampf AC, Rivière J, Geoerger B, Massaad-Massade L.
    Oncogene; 2019 Nov 01; 38(47):7200-7215. PubMed ID: 31488873
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased behavioral responses to ethanol in Lmo3 knockout mice.
    Savarese A, Zou ME, Kharazia V, Maiya R, Lasek AW.
    Genes Brain Behav; 2014 Nov 01; 13(8):777-83. PubMed ID: 25176312
    [Abstract] [Full Text] [Related]

  • 17. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.
    Cheng Y, Hou T, Ping J, Chen T, Yin B.
    J Exp Clin Cancer Res; 2018 Sep 15; 37(1):228. PubMed ID: 30219064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.